Australia and New Zealand vs Tunisia: Percentage of bloodstream infection due to methicillin-resistant
Australia and New Zealand
15.0%
in 2022
Tunisia
13.6%
in 2022
Australia and New Zealand rank
30th
Tunisia rank
33rd
Percentage of bloodstream infection due to methicillin-resistant over time
- Australia and New Zealand
- Tunisia
How they compare
Australia and New Zealand currently reports 15.0% against 13.6% in Tunisia, a difference of 1.4%.
That makes Australia and New Zealand's figure about 1.1 times Tunisia's.
The two have swapped places 2 times across 5 shared years of data; in 2018 it was Australia and New Zealand ahead.
Australia and New Zealand ranks 30th and Tunisia ranks 33rd of 50 countries.
Australia and New Zealand has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Australia and New Zealand | Tunisia | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 23.6% | 19.3% | 4.3% | Australia and New Zealand |
| 2020s | 16.5% | 15.0% | 1.5% | Australia and New Zealand |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher percentage of bloodstream infection due to methicillin-resistant, Australia and New Zealand or Tunisia?
- Australia and New Zealand, at 15.0% against 13.6% in Tunisia as of 2022.
- What is the difference in percentage of bloodstream infection due to methicillin-resistant between Australia and New Zealand and Tunisia?
- 1.4%, with Australia and New Zealand ahead.
- How many years of comparable data are there for Australia and New Zealand and Tunisia?
- 5 years are reported by both, from 2018 to 2022.
- How do Australia and New Zealand and Tunisia rank globally for percentage of bloodstream infection due to methicillin-resistant?
- Australia and New Zealand ranks 30th and Tunisia ranks 33rd of 50 countries.
- Where does this data come from?
- United Nations Statistics Division, SDG Global Database, published as Percentage of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) among patients seeking care and whose blood sample is taken and tested (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.